• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[转运体在肝脏药物处置中的作用]

[Role of transporters in hepatic drug disposition].

作者信息

Gao Chun-Ying, Chen Xiao-Yan, Zhong Da-Fang

机构信息

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

Yao Xue Xue Bao. 2012 May;47(5):565-72.

PMID:22811997
Abstract

Liver is regarded as one of the most important organs for drug clearance in the body, which mediates both the metabolism and biliary excretion of drugs. Transporters are a class of functional membrane proteins and control the movement of substances into or out of cells. Transporters, which are extensively expressed in the liver, play important roles in the drug hepatic disposition by regulating the uptake of drugs from blood into hepatocytes or the efflux of drugs and their metabolites into bile. In this review, the localization, functions and substrate selectivity of the major transporters in the liver will be summarized, and the impacts of these transporters on drug hepatic disposition, the potential drug-drug interactions as well as their genetic polymorphisms will also be reviewed.

摘要

肝脏被视为体内药物清除的最重要器官之一,它介导药物的代谢和胆汁排泄。转运体是一类功能性膜蛋白,控制物质进出细胞。转运体在肝脏中广泛表达,通过调节药物从血液进入肝细胞的摄取或药物及其代谢产物进入胆汁的外排,在药物肝脏处置中发挥重要作用。在本综述中,将总结肝脏中主要转运体的定位、功能和底物选择性,还将综述这些转运体对药物肝脏处置的影响、潜在的药物-药物相互作用及其基因多态性。

相似文献

1
[Role of transporters in hepatic drug disposition].[转运体在肝脏药物处置中的作用]
Yao Xue Xue Bao. 2012 May;47(5):565-72.
2
Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.转运体在选择性磷酸二酯酶-4抑制剂(+)-2-[4-({[2-(苯并[1,3]二氧杂环戊烯-5-基氧基)-吡啶-3-羰基]-氨基}-甲基)-3-氟-苯氧基]-丙酸在大鼠和人体内处置中的作用
Drug Metab Dispos. 2007 Nov;35(11):2111-8. doi: 10.1124/dmd.107.016162. Epub 2007 Aug 8.
3
Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.药物转运体的多种人类异构体参与了奥美沙坦(一种血管紧张素II AT1受体选择性拮抗剂)的肝脏和肾脏转运。
Drug Metab Dispos. 2007 Dec;35(12):2166-76. doi: 10.1124/dmd.107.017459. Epub 2007 Sep 6.
4
Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.有机氯农药对肝脏药物转运体活性和表达的调控
J Biochem Mol Toxicol. 2014 Mar;28(3):119-28. doi: 10.1002/jbt.21543. Epub 2013 Nov 27.
5
Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.肝脏转运体在药物及其代谢产物临床处置中的重要性。
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S23-39. doi: 10.1002/jcph.671.
6
Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.从小鼠成纤维细胞直接重编程获得的具有功能性药物转运体的优化类肝细胞及其在药物处置和毒理学中的潜力
Cell Physiol Biochem. 2016;38(5):1815-30. doi: 10.1159/000443120. Epub 2016 May 9.
7
Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.17α-乙炔基雌二醇 3-O-硫酸盐共轭物的转运体研究:人肝药物转运体的评估。
Drug Metab Dispos. 2010 Jul;38(7):1072-82. doi: 10.1124/dmd.109.031518. Epub 2010 Apr 1.
8
Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.在三明治培养的人肝细胞中评估内皮素受体拮抗剂安立生坦、波生坦、马西替坦和西他生坦作为肝胆转运体抑制剂和底物的情况。
PLoS One. 2014 Jan 30;9(1):e87548. doi: 10.1371/journal.pone.0087548. eCollection 2014.
9
Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.摄取(OATP1B1、1B3)和外排(MRP2、BCRP)转运体的遗传多态性:对他汀类药物和其他临床相关药物药代动力学和药效学个体间差异的影响。
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):703-29. doi: 10.1517/17425250902976854.
10
Species differences in drug transporters and implications for translating preclinical findings to humans.药物转运体的种属差异及其对将临床前研究结果转化为人类应用的影响。
Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):237-52. doi: 10.1517/17425255.2013.741589. Epub 2012 Dec 21.